Drug class
First-generation H1 antihistamine; antiallergic agent
Mechanism of action
Competitively antagonises histamine H1 receptors, reducing allergic symptoms including itching, sneezing and rhinorrhoea. It may also have sedative and anticholinergic effects.
General use cases
- Symptomatic treatment of allergic rhinitis, urticaria and pruritic skin disorders in countries where diphenylpyraline remains authorised; current availability is limited and jurisdiction-specific
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
